Compare Atmos Energy Corporation (ATO) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Atmos Energy Corporation vs BioNano Genomics Inc — how do they compare? Atmos Energy Corporation trades at $169.49 (market cap $28.59B), while BioNano Genomics Inc trades at $1.19 (market cap $13.66M). The key difference: Atmos Energy Corporation is far larger — about 2093× BioNano Genomics Inc's market cap, and Atmos Energy Corporation pays a 2.36% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| ATO | BNGO | |
|---|---|---|
Market Cap | $28.59B | $13.66M |
Sector | Utilities | Health |
52-Week High | $192.25 | $4.92 |
52-Week Low | $162.44 | $1.06 |
Enterprise Value | $38.40B | $16.26M |
Dividend Yield | 2.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Atmos Energy (ATO) trades at $167.92, down 1.33% today, with a bearish technical signal despite recent earnings beats. The company reported Q3 2026 EPS of $1.43, beating estimates of $1.35, with revenue growth of 4.8% year-over-year. Strong profitability metrics include a 28.5% net income margin and 62.2% gross margin, while valuation ratios show a P/E of 20.2 and P/S of 5.7. Recent corporate developments include board appointments and dividend declarations of $1.00 per share.
ATO presents a mixed outlook with solid fundamentals and analyst support but faces technical headwinds. The consensus price target of $190.57 suggests 13.5% upside potential, supported by 45% buy ratings. Risks include high capital expenditures impacting cash flow and debt levels near $7.9 billion. Earnings growth and rate approvals provide catalysts, though the stock's bearish technical trend warrants caution near-term.
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
